Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampin-resistant Tuberculosis”

Showing 3 of 0 results

Not applicableStudy completedNCT03072576
What this trial is testing

Accuracy and Feasibility of Xpert Ultra

Who this might be right for
Tuberculosis, Pulmonary
Foundation for Innovative New Diagnostics, Switzerland 1,400
Post-approval studies (Phase 4)Study completedNCT02231229
What this trial is testing

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Who this might be right for
Tuberculosis
Assistance Publique - Hôpitaux de Paris 204
Early research (Phase 1)Study completedNCT05586230
What this trial is testing

Study of a Single Dose of Pretomanid Added to an Optimized Background Regimen in Children With Rifampicin-Resistant Tuberculosis

Who this might be right for
TuberculosisRifampicin Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 32

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation